Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer

This study has been completed.
Sponsor:
Collaborators:
Canadian Urologic Oncology Group
NCIC Testis Group
German Testicular Cancer Study Group (GTSCG)
Information provided by:
British Columbia Cancer Agency
ClinicalTrials.gov Identifier:
NCT00371553
First received: September 1, 2006
Last updated: July 7, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)